Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework
Fusun Erten, Ecem Kalemoglu, Omer Kucuk, Kazim Sahin · 2026
Read Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework by Fusun Erten, Ecem Kalemoglu, Omer Kucuk, Kazim Sahin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13468118.txt.
Description
Fusun Erten and co-authors assemble a 2026 expert review on whether food- and plant-derived nutraceuticals can support care for urologic cancers, including prostate, bladder, kidney, and testicular tumors. These cancers run on interlocking pathways governing growth, blood supply, invasion, and immune escape. The review weighs lab studies, human data, and clinical evidence for compounds that touch those pathways, from signaling and oxidative balance to the tumor surroundings.
The authors are explicit that nutraceuticals are investigational add-ons, not anticancer treatments or substitutes for standard care. Their search ran across four databases up to June 2026 and included citation chasing both ways. The result is a precision-oriented framework: which compounds, which pathways, which tumor types, and what evidence tier, so doctors and researchers can tell plausible adjuncts from supplement marketing.
Catalog record
| CREATOR | Fusun Erten, Ecem Kalemoglu, Omer Kucuk, Kazim Sahin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 192042 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |